All News

In an observational cohort study, factors such as education, income, and marital status correlated with MS severity outcomes.

Asian and Hispanic/Latino veterans experience insomnia at some of the highest rates, but these patient groups are also among the least likely to seek treatment for the common sleep disorder.

The annual fall meeting of AMCP Nexus 2023 will feature discussions on the evolving managed care landscape, including the impact of the Inflation Reduction Act, the specialty pharmaceutical pipeline, insight into the growing use of diabetes drugs for weight loss, and more.

Not all children and teens with active asthma are achieving adequate control of their symptoms, and timely referral to secondary care is rare, according to one study.

Ischemic and coronary heart disease were the 2 major cardiovascular disease (CVD) subtypes contributing to hospital admissions among patients with diabetes.

Vast claims databases can yield valuable information about the unmet medical needs of patients with chronic obstructive pulmonary disease (COPD) and severe asthma, and those insights point to areas that can be improved by engaging and educating clinicians.

Two posters presented at the CHEST Annual Meeting 2023 showed how real-world exacerbation rates in asthma and chronic obstructive pulmonary disease (COPD) dropped after patients started using a single inhaler that delivers triple therapy.

Clinical studies have transformed how breast cancer is prevented, identified, and treated. Successful clinical trials improve patient outcomes, so trial administrators must ensure participants receive appropriate support at trial enrollment.

With methamphetamines continuing to inflict damage on the Western United States, panelists at the CHEST Annual Meeting 2023 shared sobering statistics and important considerations in treating patients with pulmonary hypertension associated with use of this destructive drug.

Steven Deitelzweig, MD, system chairman of hospital medicine at Ochsner Clinical School, professor of medicine at the University of Queensland, discusses key findings from a recent study on the accuracy of atrial fibrillation detection devices.

Despite improvements, hospitals struggle to meet prepandemic standards in door-to-balloon time.

Lower-sodium oxybate (LXB) and sodium oxybate (SXB) were proven equally effective for cataplexy and excessive daytime sleepiness (EDS), despite LXB having 92% less sodium.

Updated vaccines are on their way to US pharmacies; importance of early diagnosis and treatment for individuals at risk of cardiovascular disease; Walgreens pharmacists stage their own protest.

Based on the comprehensive findings of a review, investigators outline several crucial policy implications, each designed to address the complex issue of bias mitigation in clinical algorithms effectively.

Amid the impacts of climate change, industrial emissions, and environmental disasters, pulmonologists and other clinicians will need to deliver actionable advice on how to reduce the risks to lung health posed by air pollution, according to panelists at the CHEST Annual Meeting 2023.

A retrospective, population-based study reveals a possible association between COVID-19 infection and autoimmune and autoinflammatory outcomes.

A close, updated review of data used to determine how to improve lung cancer screening rates and see who is most at risk of pulmonary complications is necessary to make progress in this area, notes Ajay Sheshadri, MD, MSCI.

Increasing lung cancer screening uptake without tailoring outreach and follow-up for underserved populations risks magnifying the existing racial and ethnic disparities in screening, so thoughtful approaches are needed to close the gaps, according to speakers at the CHEST Annual Meeting 2023.

Patterns in COVID-19 vaccinations remain largely divided along political party lines, according to one report.

Patients who spoke Somali were more willing to get a screening for colorectal cancer (CRC) after a video intervention.

Sarah Boyce, president and CEO at Avidity Biosciences, discusses her leading role at the company, as well as antibody oligonucleotide conjugate drug, AOC 1044, currently in development for Duchenne muscular dystrophy (DMD) with mutations amenable to exon 44 skipping (DMD44).

A minimally invasive procedure could revolutionize breast surgery; Black women experience the worst birthing outcomes; Kaiser Permanente health workers' concerns over labor disputes persist.

New research explores the risk factors for lung disease in firefighters who were exposed to particulate matter when responding to the attacks on the World Trade Center (WTC) on September 11, 2001, as well as interventions that may mediate inflammatory responses.

As evidenced by a debate at the CHEST Annual Meeting 2023, the pulmonology community disagrees on whether the overlap of asthma and chronic obstructive pulmonary disease (COPD) is a distinct entity and how best to treat it.

Sleep problems significantly increased between the first and second waves of the COVID-19 pandemic, which might be explained by detrimental sleep hygiene practices.

The program will initially allow 6 sponsors of clinical trials to participate and will provide sponsors with the opportunity for frequent advice and regular communication regarding clinical trial design and other development issues.

Pinky, a mobile mammography unit from Stony Brook University Hospital Cancer Center on Long Island, increased screening for breast cancer from 9% to 69% among the predominantly Latina population that it serves.

Rajini Katipamula-Malisetti, MD, executive vice president at Minnesota Oncology, discussed what her practice is doing to continue improving patient care.

In the overall population of more than 1.3 million US adults, 37% of patients reported being diagnosed with T1D after 30 years, with men and racial or ethnic minorities diagnosed later compared with women and non-Hispanic White adults.

Annualized costs for the 24-month study period were highest among patients with both NASH and T2D, highlighting the incremental cost of adding an additional diagnosis for comorbid NASH or T2D.